M Chakos

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials
    M Chakos
    Department of Psychiatry, University of North Carolina School of Medicine, CB7160, Chapel Hill, NC 27599 7160, USA
    Am J Psychiatry 158:518-26. 2001
  2. ncbi Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder
    D Robinson
    Department of Psychiatry, Hillside Hospital, Long Island Jewish Medical Center, Glen Oaks, NY 11004, USA
    Arch Gen Psychiatry 56:241-7. 1999
  3. ncbi Longitudinal study of brain morphology in first episode schizophrenia
    J Lieberman
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA
    Biol Psychiatry 49:487-99. 2001
  4. ncbi IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illness
    B B Sheitman
    Department of Psychiatry, University of North Carolina, Chapel Hill, NC, USA
    Schizophr Res 46:203-7. 2000
  5. ncbi The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches
    J A Lieberman
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA
    Biol Psychiatry 50:884-97. 2001

Collaborators

  • J Volavka
  • M G Woerner
  • J A Lieberman
  • D Robinson
  • J Lieberman
  • B B Sheitman
  • R Bilder
  • R Goldman
  • J Alvir
  • A Belger
  • E Hoffman
  • H Wu
  • K Boteva
  • D Perkins
  • J Gilmore
  • F Jarskog
  • J A Snyder
  • M G Murray
  • S Silva
  • B Sheitman
  • S Geisler
  • J M Alvir
  • A Koreen
  • D Mayerhoff

Detail Information

Publications5

  1. ncbi Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials
    M Chakos
    Department of Psychiatry, University of North Carolina School of Medicine, CB7160, Chapel Hill, NC 27599 7160, USA
    Am J Psychiatry 158:518-26. 2001
    ..The authors conducted a review and meta-analysis of studies that compared the efficacy and tolerability of typical and second-generation antipsychotics for patients with treatment-resistant schizophrenia...
  2. ncbi Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder
    D Robinson
    Department of Psychiatry, Hillside Hospital, Long Island Jewish Medical Center, Glen Oaks, NY 11004, USA
    Arch Gen Psychiatry 56:241-7. 1999
    ..We examined relapse after response to a first episode of schizophrenia or schizoaffective disorder...
  3. ncbi Longitudinal study of brain morphology in first episode schizophrenia
    J Lieberman
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA
    Biol Psychiatry 49:487-99. 2001
    ..There is also a need to control for treatment effects of typical antipsychotic medication on brain structure...
  4. ncbi IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illness
    B B Sheitman
    Department of Psychiatry, University of North Carolina, Chapel Hill, NC, USA
    Schizophr Res 46:203-7. 2000
    ..807, P < 0.0001), while duration of illness (10-40 years) was unrelated to the magnitude of IQ score decline (r = -0.103, P = 0.575). These data suggest that pre-morbid IQ test scores are highly predictive of post-morbid scores...
  5. ncbi The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches
    J A Lieberman
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA
    Biol Psychiatry 50:884-97. 2001
    ..Because the clinical deterioration that occurs in schizophrenia may actually begin in the prepsychotic phase, early identification and intervention may favorably alter the course and outcome of schizophrenia...